Skip to main content

HLA-DRB1 alleles and treatment response in RA

Presenter: Vivian Bykerk, Hospital for Special Surgery, New York, USA.

Saturday 15 June: 08:00–09:00 (Abstract LB0008)

This head-to-head study of abatacept versus adalimumab recruited biologic-naïve individuals with early rheumatoid arthritis, and aimed to investigate whether HLA-DRB1 alleles containing the shared epitope influence the clinical efficacy of the agents.

More on this trial